Critical Reviews in Oncology / Hematology
Volume 74, Issue 3 , Pages 203-210 , June 2010

Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy

  • Matti Aapro

      Affiliations

    • Institut Multidisciplinaire d’Oncologie (IMO), Clinique de Genolier, 1 Route du Muids, 1272 Genolier, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 22 366 91 06; fax: +41 22 366 91 31.
  • ,
  • Matthias Schwenkglenks

      Affiliations

    • European Center of Pharmaceutical Medicine, University of Basel, Basel, Switzerland
  • ,
  • Gary H. Lyman

      Affiliations

    • Duke University Medical Center, Durham, NC, United States
  • ,
  • Antonio Lopez Pousa

      Affiliations

    • Medical Oncology, Hospital de Sant Pau, Barcelona, Spain
  • ,
  • Susan Lawrinson

      Affiliations

    • Biostatistics, Amgen Ltd, Uxbridge, United Kingdom
  • ,
  • Tomas Skacel

      Affiliations

    • Clinical Development, Amgen (Europe) GmbH, Zug, Switzerland
    • Internal Medicine – Hematoonkology, University Hospital, Brno, Czech Republic
  • ,
  • Pamela Bacon

      Affiliations

    • Clinical Development, Amgen (Europe) GmbH, Zug, Switzerland
  • ,
  • Gunter von Minckwitz

      Affiliations

    • German Breast Group, GBG Forschungs GmbH, University of Frankfurt, Frankfurt, Germany

,Accepted 18 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1040-8428(09)00124-3

doi: 10.1016/j.critrevonc.2009.06.004

Critical Reviews in Oncology / Hematology
Volume 74, Issue 3 , Pages 203-210 , June 2010